
Brunei Sultan discharged from IJN
KUALA LUMPUR: Sultan of Brunei, Sultan Hassanal Bolkiah has been discharged from hospital and will remain in the Malaysian capital for a few more days to rest, his office said on Saturday.
Sultan Hassanal was admitted to hospital in Kuala Lumpur on Tuesday due to fatigue, though his office had insisted the world's longest-serving monarch was in "good health."
"His Majesty Sultan Hassanal Bolkiah ... praise be to God, is back at the Grand Hyatt Hotel after resting a few days at the National Heart Institute, Kuala Lumpur," his office said in an Instagram post on Saturday.
"Medical experts have advised His Majesty to continue resting for a few more days before departing back to Brunei."
The 78-year-old sultan was in Kuala Lumpur for a summit with other Association of Southeast Asian Nations leaders.
A statement from the Brunei prime minister's office – a position held by the sultan – on Tuesday said the monarch had been feeling tired and that Malaysian health experts had advised him to rest for a few days at the National Heart Institute.
Sultan Hassanal ascended the throne in 1967.
He is one of the richest people on the planet, and comes from a family that has ruled Brunei, a small Muslim nation perched on the north of the tropical island of Borneo, for more than 600 years.
His decades ruling Brunei have seen the country gain full independence from Britain and living standards soar to among the highest globally.
-AFP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
2 hours ago
- The Star
M'sia leads medical tourism charge
PETALING JAYA: From the Maldives to mainland China, foreigners are drawn to the world-class healthcare offered by private hospitals in the country, says Association of Private Hospitals Malaysia president Datuk Dr Kuljit Singh (pic). Apart from being cost-effective, these foreign patients were keen on the transparent healthcare plans offered by Malaysian private hospitals, he said. Another plus factor for them was the ease of communication as English is widely spoken, he said in an interview. Last Wednesday, the Health Ministry announced that Malaysia has been ranked as the top destination for medical tourism based on quality, infrastructure, cost-effectiveness and ease of access by Nomad Capitalist, a Dubai-based wealth consultancy firm. Health Minister Datuk Seri Dr Dzulkefly Ahmad said in a Facebook post that Malaysia's medical tourism sector generated about RM2bil in revenue in 2023, with 1.3 million foreigners seeking treatment in the country. Dr Kuljit told The Star that foreign nationalities who sought treatment are mainly from Indonesia, China, Bangladesh and the Maldives. The rest are from Europe and the United States. 'We are way more affordable compared to our neighbouring countries and far cheaper than western countries,' he said, estimating that foreign patients seeking treatment in Malaysia would be paying 20% to 50% lower than elsewhere. 'For those from the US, the savings could be up to 70% compared to what they would need to fork out in their own country.' He said foreign patients seek a variety of treatments ranging from simple health screening to sophisticated interventions. Dr Kuljit said that being a predominantly Muslim country was also advantageous as it was a plus point for Muslim patients. 'Another factor that has earned the trust and confidence of international patients are Malaysia's strict healthcare standards and accreditation with global medical bodies. 'They are treated with care and only discharged when they are fit to leave the facility,' he added. However, while medical care is seamlessly rendered, Dr Kuljit acknowledged that the biggest challenge private hospitals face is inadequate capacity for inpatients. 'A shortage of manpower such as nurses is an issue,' he said. Furthermore, he said restrictions and conditions imposed on private hospitals that curtail healthcare costs can prove to be a hindrance to the growth of medical tourism. But in the long term, he said Malaysia's future as a medical tourism hub remains bright as the projected number of patients exceeds targets annually. 'I am confident that Malaysia's reputation as one of the leading medical tourism destinations in the world will only continue to grow in leaps and bounds as private hospitals in Malaysia remain committed to delivering reliable, world-class care to Malaysians first and foremost and to the rest of the world,' he added. Dr Kuljit said Malaysians no longer need to travel abroad in search of premium healthcare. 'However, these advantages are sometimes overlooked by Malaysians and lead to a misunderstanding of the role of private hospitals. There is a mistaken notion that the services offered are medical tourism-oriented and solely driven by profit,' he said. He explained that private hospitals strive to improve continuously to meet world-class standards that benefit both the local population and medical tourists. Asked if private hospitals would extend their services to low-income Malaysians as part of their corporate social responsibility since they have earned revenue from medical tourism, he said such initiatives will be further enhanced if private hospitals managed to increase capacity. 'We are happy to work with the public healthcare system and conduct such programmes but we need to have greater capacity and manpower,' he said.


New Straits Times
2 hours ago
- New Straits Times
New hope for patients with less common breast cancer
WASHINGTON: A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, researchers reported Monday. Results from the study, presented at the annual meeting of the American Society for Clinical Oncology, are expected to be submitted to regulators and could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer – the advanced stage of a form that comprises 15–20 per cent of all breast cancer cases. HER2-positive cancers are fuelled by an overactive HER2 gene, which makes too much of a protein called human epidermal growth factor receptor 2 that helps cancer cells grow and spread. Patients with HER2-positive breast cancer that has spread to other parts of the body live around five years. "Seeing such a striking improvement was really impressive to us – we were taking a standard and almost doubling how long patients could have their cancer controlled for," said oncologist Sara Tolaney, chief of the breast oncology division at Dana-Farber Cancer Institute, speaking to AFP. The current standard of care, known as THP, combines chemotherapy with two antibodies that block growth signals from the HER2 protein. The new approach uses a drug called trastuzumab deruxtecan (T-DXd), an antibody attached to a chemotherapy drug. This "smart bomb" strategy allows the drug to target cancer cells directly. "You can bind to the cancer cell and dump all that chemo right into the cancer cells," explained Tolaney. "Some people call them smart bombs because they're delivering chemo in a targeted fashion – which is how I think we're able to really increase efficacy so much." Common side effects included nausea, diarrhoea and a low white blood cell count, with a less common effect involving lung scarring. T-DXd is already approved as a "second-line" option – used when first-line treatments stop working. But in the new trial, it was given earlier, paired with another antibody, pertuzumab. In a global trial led by Tolaney, just under 400 patients were randomly assigned to receive T-DXd in combination with pertuzumab, thought to enhance its effects. A similar number received the standard THP regimen. A third group, who received T-DXd without pertuzumab, was also enrolled – but those results haven't yet been reported. At a follow-up of 2.5 years, the T-DXd and pertuzumab combination reduced the risk of disease progression or death by 44 per cent compared to standard care. Fifteen per cent of patients in the T-DXd group saw their cancer disappear entirely, compared to 8.5 per cent in the THP group. Because this was an interim analysis, the median progression-free survival – meaning the point at which half the patients had seen their cancer return or worsen – was 40.7 months with the new treatment, compared to 26.9 months with the standard, and could rise further as more data come in. Tolaney said the results would be submitted to regulators around the world, including the US Food and Drug Administration, and that future work would focus on optimising how long patients remain on the treatment, particularly those showing complete remission. "This represents a new first-line standard treatment option for HER2-positive metastatic breast cancer," said Dr Rebecca Dent, a breast cancer specialist at the National Cancer Center Singapore who was not involved in the study.


New Straits Times
10 hours ago
- New Straits Times
Father of six killed by Israeli fire 'for piece of bread' during Gaza aid queue
KHAN YUNIS, Palestinian Territories: Cries of grief echoed across southern Gaza's Nasser Hospital Monday as dozens came to mourn Hossam Wafi, after the father of six was killed while attempting to get supplies to feed his family. His mother, Nahla Wafi, sobbed uncontrollably over her son, who was among 31 people killed by Israeli fire while trying to reach a food distribution site the previous day, according to the Palestinian territory's civil defence agency. "He went to get food for his daughters – and came back dead," said Nahla Wafi, who lost two sons and a nephew on Sunday. Hossam Wafi had traveled with his brother and nephew to a newly established distribution centre in the southern city of Rafah. "They were just trying to buy (flour). But the drone came down on them," his mother said, as she tried to comfort four of her granddaughters in the courtyard of Nasser Hospital in Khan Yunis. Israel has faced growing condemnation over the humanitarian crisis in the war-ravaged Gaza Strip, where the United Nations has warned the entire population faces the risk of famine. The International Committee of the Red Cross (ICRC) said that its field hospital in Rafah received 179 cases on Sunday, including 21 pronounced dead on arrival. The ICRC said that all those wounded "said they had been trying to reach an aid distribution site", and that "the majority suffered gunshot or shrapnel wounds." Israeli authorities and the Gaza Humanitarian Foundation, a US and Israeli-backed outfit that runs the distribution centres, denied any such incident took place. The military instead said that troops fired "warning shots" at people who approached them one kilometre away from the Rafah distribution site before dawn. A witness told AFP thousands of people gathered at the area, known locally as the Al-Alam junction, between 2 and 4am (2300 GMT and 0100 GMT) in the hopes of reaching the distribution centre. At Nasser Hospital, Hossam Wafi's young daughters called out for their father, kissing his body wrapped in a white shroud, before it was taken away. Outside the hospital, dozens of men stood in silence before the body, praying. Some cried as the remains were taken away, one of them holding the father's face until he was gently pulled away. His uncle, Ali Wafi, told AFP he felt angry his nephew was killed while trying to get aid. "They go there and get bombed – airstrikes, tanks, shelling – all for a piece of bread," he said. "He went for a bite of bread, not for anything else. What was he supposed to do? He had to feed his little kids. And the result? He's getting buried today," he added. The deaths in Rafah were one of two deadly incidents reported by Gaza's civil defence agency on Sunday around the GHF centres, which the UN says contravene basic humanitarian principles and appear designed to cater to Israeli military objectives. There have been several other reports of chaotic scenes and warning shots fired in connection with the distribution sites over the past week. The UN's humanitarian agency (OCHA) published a video of one such distribution site in central Gaza's Netzarim corridor on Thursday. A large crowd is seen gathered around four long corridors made from metal fences installed in the middle of an arid landscape, corralling men and women into files to receive flour. The distribution site and its waiting area sit on a flattened piece of land surrounded by massive mounds of soil and sand. It is manned by English-speaking security guards travelling in armoured vehicles. Palestinians exiting the distribution area carry cardboard boxes sometimes bearing a "GHF" logo, as well as wooden pallets presumably to be repurposed as fuel or structures for shelter. In the large crowd gathered outside the gated corridors, some men are seen shoving each other, and one woman complains that her food package was stolen. Hossam Wafi's uncle Ali said he wished Gaza's people could safely get aid. "People take the risk (to reach the distribution site), just so they can survive."--AFP